Crossbow Therapeutics, Inc
Sarah Jaffe is a skilled scientist currently serving as Scientist I at Crossbow Therapeutics, Inc. since June 2023. Previously, Sarah held various roles at Jounce Therapeutics, Inc., culminating in the position of Senior Associate Scientist, where responsibilities included analytical representation for multispecific and antibody programs and conducting CMC stability studies. Additional experience includes developing liquid infused surfaces as a Biomedical Engineering Co-op at LiquiGlide and tutoring upperclassmen in chemical engineering at Northeastern University. Sarah's early career features positions such as Protein Analytics Co-op at Jounce, Protein Purification Process Development Co-op at Pfizer, and Research Assistant in Dr. Thomas Webster's lab. Sarah Jaffe earned a degree in Chemical Engineering from Northeastern University, completing studies in 2019.
Crossbow Therapeutics, Inc
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.